Literature DB >> 1440458

The cost of care in cystic fibrosis.

D J Shale.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1440458      PMCID： PMC474796          DOI： 10.1136/thx.47.9.673

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  4 in total

1.  Cystic fibrosis. 7. Management of cystic fibrosis in different countries. Cystic fibrosis in Melbourne.

Authors:  P D Phelan; G Bowes
Journal:  Thorax       Date:  1991-05       Impact factor: 9.139

2.  Cystic fibrosis. 7. Management of cystic fibrosis in different countries. Cystic fibrosis in Copenhagen.

Authors:  C Koch; N Høiby
Journal:  Thorax       Date:  1991-05       Impact factor: 9.139

3.  Cystic fibrosis: current survival and population estimates to the year 2000.

Authors:  J S Elborn; D J Shale; J R Britton
Journal:  Thorax       Date:  1991-12       Impact factor: 9.139

4.  A cost description of an adult cystic fibrosis unit and cost analyses of different categories of patients.

Authors:  M Robson; J Abbott; K Webb; M Dodd; J Walsworth-Bell
Journal:  Thorax       Date:  1992-09       Impact factor: 9.139
  4 in total
  1 in total

Review 1.  Dornase alfa. A review of pharmacoeconomic and quality-of-life aspects of its use in cystic fibrosis.

Authors:  K L Goa; H Lamb
Journal:  Pharmacoeconomics       Date:  1997-09       Impact factor: 4.981
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.